Organisation mondiale de la santé (OMS) · Press Releases, Fact Sheets, Newsletters, Statements

MERS situation update: October 2021

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

The aim of this situation update is to provide the epidemiological status of MERS in the Region in order to aid better planning, coordination and response. The information in this document has been reported to WHO by Ministries of Health. For further information, contact: Tel + 20-2-22765492, Fax + 20-2-2765456 E-mail: emrgohspoutbreak@who Published by World Health Organization Regional Office for the Eastern Mediterranean Monazamet El Seha El Alamia Str,Extension of Abdel Razak El Sanhouri Street P.O. Box 7608, Nasr City Cairo 11371, Egypt www.emro.who.int © World Health Organization 2021 Highlights MERS SITUATION UPDATE | OCTOBER 2021 Distribution of MERS reported cases from Eastern Mediterranean Region by week of onset, June 2012 – October 2021 Tunisia United Arab Emirates Bahrain Egypt Iran (Islamic republic of) Jordan Kuwait Lebanon Oman Qatar Yemen Saudi Arabia 0 20 40 60 80 100 120 140 N um be r of c as es No new cases of MERS were reported to WHO during the month of October 2021. At the end of October 2021, a total of 2578 laboratory-confirmed cases of Middle East respiratory syndrome (MERS), including 888 associated deaths were reported globally for a case-fatality ratio (CFR) of 34.4%. The majority of these cases were reported from Saudi Arabia, which had 2178 cases including 810 related deaths (CFR 37.2%). The demographic and epidemiological characteristics of reported cases during the last 6 months, when compared to the same corresponding periods from 2016 to 2021, do not show any significant difference or change. The reported cases between June 2012 and October 2021 indicate that the age group 50–59 years continues to be at the highest risk for acquiring infection as primary cases. The age group 30–39 years is most at risk for as secondary cases. The number of deaths is higher in the age group 50–59 years as primary cases and 70–79 years as secondary cases. . . . . SUMMARY 2578 Laboratory-confirmed cases reported since April 2012 888 Deaths reported since April 2012 27 Countries reported cases globally 12 Countries reported cases since April 2012 in the Eastern Mediterranean Region Epidemiological characteristics of MERS cases reported globally between May - October 2016 and May - October 2021 Characteristic Number Median age in years Gender (% male) % of Primary Cases % of Secondary cases (%) of Unknown Contact History % of HCW % Fatal May - Oct 16 97 52 63 35 30 8 23 22 May - Oct 17 145 48 68 23 49 0 27 24 May - Oct 18 58 54 90 40 31 2 2 28 May - Oct 19 56 55 80 32 11 18 7 32 May - Oct 20 7 71 100 14 71 0 14 57 May - Oct 21 3 65 100 100 0 0 0 0 Characteristics of MERS cases reported from Saudi Arabia, June 2012 - October 2021 Type of case Missing Primary Secondary Unknown Grand Total 2012 3 2 5 2013 1 36 93 28 158 2014 15 164 264 219 662 2015 102 52 222 78 454 2016 103 75 60 11 249 2017 68 70 90 5 233 2018 52 54 35 1 142 2019 56 57 75 16 204 2020 7 11 9 33 60 2021 2 7 2 11 Grand Total 406 529 850 393 2178 MERS cases per week of onset in Saudi Arabia, June 2012 – October 2021 Survived Died Age and fatality distribution of primary and secondary cases of MERS reported from Saudi Arabia June 2012 – October 2021 30 25 20 15 10 5 0 5 10 15 20 25 00-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90&> 90 % A ge G ro u p Survived Died Primary Secondary Cases of MERS in healthcare workers reported from Saudi Arabia, January 2013 – October 2021 0 50 100 150 200 250 N u m b er o f ca se s Month Non-HCW HCW Community versus hospital acquired MERS cases in Eastern Mediterranean Region, January 2014 – October 2021 Community acquired Hospital acquired 0 10 20 30 40 50 60 70 80 90 100 N um be r of M ER S ca se s Epi week 2014 2015 2016 2017 2018 2019 2020 2021 Year 0 50 100 150 200 250 300 N u m b er o f ca se s Epi week Document number: WHO-EM/CSR/471/E 172329354147 1 7 13192531374349 3 9 15212733394551 4 1016222834404652 6 12182430364248 2 8 14202632384450 4 10162228344046 1 7 13192531374349 3 9 15212733394551 5 111723293541 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 22 28 34 40 46 52 6 12 18 24 30 36 42 48 1 7 13 19 25 31 37 43 49 2 8 14 20 26 32 38 44 50 4 10 16 22 28 34 40 46 52 6 12 18 24 30 36 42 48 2 8 14 20 26 32 38 44 50 4 10 16 22 28 34 40 46 1 7 13 19 25 31 37 43 49 3 9 15 21 27 33 39 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 2013 2014 2015 2016 2017 2018 2019 2020 2021

Informations clés
Date d'adoption
Source Organisation mondiale de la santé